Nick Finer

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

W. P. T. James, Ian D. Caterson, Walmir Coutinho et al. · New England Journal of Medicine · 2010 · 934 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

W. P. T. James, Arne Astrup, Nick Finer et al. · The Lancet · 2000 · 820 citations

Agriculture, Nutritional Sciences, Pharmacotherapy +9

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Arne Astrup, Raffaele Carraro, Nick Finer et al. · International Journal of Obesity · 2011 · 757 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

André Scheen, Nick Finer, Priscilla Hollander et al. · The Lancet · 2006 · 736 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Management of Obesity in Adults: European Clinical Practice Guidelines

Constantine Tsigos, Vojtěch Hainer, Arnaud Basdevant et al. · Obesity Facts · 2008 · 444 citations · Full text

Public Health, Internal Medicine, Evidence-based Practice +15